The pharmaceutical company reported higher sales and stronger operating margins, while bouncing back from a loss in the previous quarter that was weighed down by a one-time expense.
The pharmaceutical company reported higher sales and stronger operating margins, while bouncing back from a loss in the previous quarter that was weighed down by a one-time expense.